TP53 and hepatocellular carcinoma: We also show that miR-103a-3p promotes HCC cell growth by downregulating TP53 and promotes HCC cell migration by upregulating JAK2/STAT3 pathway in an EVA1A-dependent manner, thereby inhibiting apoptosis and enhancing proliferation and metastasis.